[Revascularization of the hibernated myocardium: a clinical problem still unsolved]

Enrico Ammirati1, Valentina Guida, Ornella E Rimoldi

  • 1Dipartimento Cardio-Toraco-Vascolare, Universitta Vita-Salute e Istituto Scientifico, San Raffaele, Milano.

Giornale Italiano Di Cardiologia (2006)
|February 11, 2012
PubMed

Insights

Identifying hibernating myocardium is key for revascularization success in heart failure patients. This review examines evidence and proposes future trials for improving outcomes in ischemic left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Context:

  • Chronic left ventricular systolic dysfunction in coronary artery disease presents uncertain outcomes after revascularization.
  • Identifying viable but dysfunctional myocardium (hibernating myocardium) is crucial for predicting recovery.
  • Advances in medical therapy and devices have improved prognosis for heart failure patients.

Purpose:

  • To review pathophysiological mechanisms, clinical studies, and meta-analyses on revascularization for ischemic left ventricular dysfunction.
  • To discuss the role of hibernating myocardium in predicting functional recovery post-revascularization.
  • To propose a future randomized trial assessing revascularization's prognostic impact on hibernating myocardium.

Summary:

  • The mid- to long-term outcomes of revascularization in patients with chronic left ventricular systolic dysfunction due to coronary artery disease remain uncertain.
  • Hibernating myocardium, identified by advanced imaging, can predict functional recovery after revascularization.
  • The STICH trial assessed revascularization's prognostic benefit in addition to optimal medical therapy for ischemic left ventricular dysfunction.

Impact:

  • Understanding hibernating myocardium aids in selecting appropriate patients for revascularization, potentially improving functional recovery.
  • This review synthesizes four decades of research, informing clinical decision-making and future research directions.
  • A proposed trial aims to definitively assess the prognostic value of revascularizing hibernating myocardium.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...